Literature DB >> 10639236

Is "Lethal Reperfusion" an Oxymoron?

.   

Abstract

Entities:  

Year:  1997        PMID： 10639236     DOI： 10.1023/a:1017571006048

Source DB:  PubMed          Journal:  J Thromb Thrombolysis        ISSN： 0929-5305            Impact factor:   2.300


× No keyword cloud information.
  9 in total

Review 1.  Protective effects of adenosine in the reversibly injured heart.

Authors:  R D Lasley; R M Mentzer
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

Review 2.  Myocardial reperfusion injury: experimental evidence and clinical relevance.

Authors:  P R Hansen
Journal:  Eur Heart J       Date:  1995-06       Impact factor: 29.983

Review 3.  The potential for endogenous myocardial antioxidants to protect the myocardium against ischaemia-reperfusion injury: refreshing the parts exogenous antioxidants cannot reach?

Authors:  S E Steare; D M Yellon
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

Review 4.  Metabolic disturbances during myocardial ischemia and reperfusion.

Authors:  R Ferrari
Journal:  Am J Cardiol       Date:  1995-08-24       Impact factor: 2.778

Review 5.  Coronary artery endothelial function after myocardial ischemia and reperfusion.

Authors:  J F Seccombe; H V Schaff
Journal:  Ann Thorac Surg       Date:  1995-09       Impact factor: 4.330

6.  Transgenic mice expressing the human heat shock protein 70 have improved post-ischemic myocardial recovery.

Authors:  J C Plumier; B M Ross; R W Currie; C E Angelidis; H Kazlaris; G Kollias; G N Pagoulatos
Journal:  J Clin Invest       Date:  1995-04       Impact factor: 14.808

Review 7.  The contribution of ionic imbalance to ischemia/reperfusion-induced injury.

Authors:  G N Pierce; M P Czubryt
Journal:  J Mol Cell Cardiol       Date:  1995-01       Impact factor: 5.000

Review 8.  The stunned myocardium: prolonged, postischemic ventricular dysfunction.

Authors:  E Braunwald; R A Kloner
Journal:  Circulation       Date:  1982-12       Impact factor: 29.690

9.  Humanized monoclonal antibody DREG-200 directed against I-selectin protects in feline myocardial reperfusion injury.

Authors:  M Buerke; A S Weyrich; T Murohara; C Queen; C K Klingbeil; M S Co; A M Lefer
Journal:  J Pharmacol Exp Ther       Date:  1994-10       Impact factor: 4.030
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.